Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Novel Formulation Strategies

Novel Formulation Strategies

Date: Thursday, 12 April 2018 - Friday, 13 April 2018
Location: Mumbai


"Novel Formulation Strategies" is a unique, Pharma Industry focused, event designed to discuss novel strategies for pharmaceutical product development. India is the largest manufacturer of generic medicines globally and therefore drug formulation strategies need to be updated and discussed in order to successfully develop novel formulations. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.

Academic Innovation Session: In this event a special session has been designated towards Academic Innovations. A large number of Pharmaceutical Scientists in Academic Institutions have been working on formulation development. In this session we aim to present selected Academic Formulation related Innovations which might have importance in industry but could otherwise go unnoticed by industry scientists. This session will be open to Regular PhD Research Scholars only. Each presentation will be for 5-10 minutes duration only and will be adjudged by the industry scientists. The presentation providing best innovation and/or solution with direct application in pharmaceutical industry will be awarded Rs 5100/-during the closing ceremony of the conference. In addition the 2nd and 3rd position presentations will be awarded Rs 3100/- and Rs 2100/- respectively. Faculty (Registered Indian Delegate) presenting the innovation will not be eligible for the award but will be allowed to present.

The last date for submission of abstract for presentation in this session is upto February 15, 2018. The selected abstracts will be intimated latest by February 20, 2018. The selected presenters will be required to complete the registration process latest by March 1, 2018. Those not registering by the said date will lose the opportunity to present and the same will be offered to the next candidate. 

Who Should Attend: Pharmaceutical Industry Scientists working in Formulation R & D or Product Development, Technology Transfer & Novel Drug Delivery Systems, Technical Experts in Pharmaceutical Manufacturing and Experts in Pharmaceutical Business Development

Date & Venue: April 12-13, 2018 in Mumbai, India

Sponsorship Options: Pharmaceutical Industry willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Agenda Topics

  • 505(b)2 – Innovations for US Market
  • Academic Innovations in Formulation Development
  • Bioequivalence Strategies for Oral Extended / Modified Release Formulations
  • Biowaiver Strategies for BCS -1 to BCS -3 Oral Solids Dosage Forms
  • Delivery of Protein Therapeutics & Biologicals
  • Formulation of Water Insoluble Drugs for IV Injections
  • Lipid Based Drug Delivery Systems
  • QbD Approaches in Formulation Development
  • Solubility & Oral Bioavailability Enhancement
  • Spray Systems for Nasal and Permeation Enhanced Topical Preparations
  • Stability Issues with Formulations and Complex Generics
  • Strategies for Herbal Medicines
  • Taste Masking & Stability of Pediatric PFOS Dosage Forms
  • Temperature or Moisture Sensitive / Difficult to Formulate FDC Development Approaches

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Yogeshwar Bachhav, Associate Director Pharmaceutical Development, AiCuris Anti-infective Cures GmbH
Sanjay Bajaj, Managing Director, Select Biosciences India Pvt Ltd
Rakesh Bhasin, Head-Formulation, Biocon
Milind Biyani, Director, Aspire Advisors Private Limited
Sudhakar Garad, Global Head,Chemical and Pharmaceutical Profiling, Novartis
Ashish Gogia, Senior Vice President, Medreich Ltd
Hemgir Gosavi, Head-Formulation Lab, Merck
Nilesh Jaiswal, Ex-R&D HME Lead, Reckitt Benckiser
Nitin Kadam, CEO, Shadow Pharma Ventures Pvt Ltd.
Arun Kedia, Managing Director, VAV Lipids Pvt. Ltd.
Farnoosh Kianfar, Advanced Formulation Scientist, Nemaura Pharmaceuticals
Anil Kumar Gandhi, Director,Formulation Development, Rubicon Research Pvt. Ltd
Aditya Murthy, Senior Research Investigator, BBRC/Syngene International Ltd.
Sven Stegemann, Director, Capsugel
Rajan Verma, Director, Abbott Healthcare

Invited Speakers

Olivier Brass, Discovery Scientist, Sanofi Pasteur
Eric Galia, Director, Research and Development , Grunenthal Gmbh
Salman Muzammil, Director, Janssen, Pharmaceutical Companies of Johnson and Johnson
Satish Singh, Head, Lonza Inc
Deepak Thassu, Vice President, Nexgen Pharma Inc.

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-04-12 00:00:002018-04-13 00:00:00Europe/LondonNovel Formulation StrategiesNovel Formulation Strategies in